← Back to Clinical Trials
Recruiting NCT06823518

NCT06823518 Thrive Initiative Parent-Education Programming Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06823518
Status Recruiting
Phase
Sponsor Penn State University
Condition Child Maltreatment
Study Type INTERVENTIONAL
Enrollment 480 participants
Start Date 2026-03-31
Primary Completion 2028-06-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Thrive Initiative Parent-Education Programming

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 480 participants in total. It began in 2026-03-31 with a primary completion date of 2028-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to evaluate the effectiveness of the Thrive Initiative's parent-education program delivery methods by comparing hybrid (i.e., a combination of online and group components) program delivery to online-only program delivery. The Thrive Initiative consists of four, universal parent-education programs that correpsond to specific child developmental periods. These programs inlcude: Take Root for parents/caregivers of 0-3-year-old children; Sprout for parents/caregivers of 3-5-year-old children; Grow for parents/caregivres of 5-10-year-old children; and Branch Out for parents/caregivers of 10-18-year-old children. The effectiveness of delivery method will be examined for each program. Eligible participants for this study will be United States Air Force service members or dependents who are caregivers of a child 0-18 years old. The study will involve randomization to condition meaning that participants will be assigned to the online-only or hybrid program delivery condition by chance.

Eligibility Criteria

Inclusion Criteria: * United States Air Force service member or dependent * Parent/caregiver of a child 0-18 years old * 18 years of age or older * Willing to participate in the research study * Has access to technology that will enable them to receive and respond to various technological aspects of the Thrive Initiative programs and research study * Able to speak and understand English proficiently * Able to understand and give consent Exclusion Criteria: * Not an United States Air Force service member or dependent * Not a parent/caregiver of a child 0-18 years old * 17 years of age or younger * Unwilling to participate in the research study * Does not have access to technology that will enable them to receive and respond to various technological aspects of the Thrive Initiative programs and research study * Unable to speak and understand English proficiently * Unable to understand and give consent

Contact & Investigator

Central Contact

Daniel F Perkins, PhD

✉ dfp102@psu.edu

📞 8148674182

Principal Investigator

Daniel F Perkins, PhD

PRINCIPAL INVESTIGATOR

The Pennsylvania State University

Frequently Asked Questions

Who can join the NCT06823518 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Child Maltreatment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06823518 currently recruiting?

Yes, NCT06823518 is actively recruiting participants. Contact the research team at dfp102@psu.edu for enrollment information.

Where is the NCT06823518 trial being conducted?

This trial is being conducted at University Park, United States.

Who is sponsoring the NCT06823518 clinical trial?

NCT06823518 is sponsored by Penn State University. The principal investigator is Daniel F Perkins, PhD at The Pennsylvania State University. The trial plans to enroll 480 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology